Eptifibatide for stroke treatment 4.5 to 24 hours after symptoms
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a drug called eptifibatide for people who have had an ischemic stroke and did not fully improve after standard clot-dissolving treatment. It aims to see if this medicine can help prevent further worsening or improve recovery when given up to 24 hours after stroke onset.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had an ischemic stroke and it has been 4.5 to 24 hours since you were last known to be well.
- Your stroke symptoms are at least moderate (NIHSS score 4 or more) before the study drug.
- After receiving standard clot-dissolving treatment (thrombolysis), you had no significant improvement, got worse, or had fluctuating symptoms within 24 hours.
- You can receive the study drug within 60 minutes after finishing thrombolysis.
- You do not have a known cause of stroke from a heart condition (like atrial fibrillation or recent heart attack), planned procedures to remove clots, active bleeding, or certain other medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a medication called tirofiban can help people who had a stroke 4.5 to 24 hours ago and received clot-dissolving treatment (IVT). If you have had a stroke and your symptoms did not improve or got worse after IVT, this study might offer a way to prevent further disability.
This trial tests whether giving tirofiban (a blood thinner) shortly after the standard clot-busting drug tenecteplase can improve recovery from a moderate stroke. It is for people who have had a stroke within the last few hours and do not have certain risk factors like irregular heart rhythm or recent bleeding.
This trial tests if a drug called tirofiban, given after clot removal and clot-busting medicine, can help people with a specific type of stroke caused by a hardened artery. It aims to see if it improves recovery and prevents new clots.
This trial tests if a procedure to remove blood clots from brain arteries can help people who had a stroke more than 24 hours ago (up to 30 days). It aims to see if this treatment improves recovery for those with moderate to severe stroke symptoms.
This trial tests a clot-dissolving medicine called tenecteplase for people who had a stroke more than 4.5 hours ago. It may help you recover if given later than usual.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.